Feline Hyperthyroidism – A Comprehensive Medical Guide

Overview

Feline hyperthyroidism is a common endocrine disorder in older cats, characterized by excessive production of thyroid hormones (thyroxine [T4] and triiodothyronine [T3]) by the thyroid glands located at the base of the neck. The condition generally results in a markedly increased metabolic rate.

Who it affects: The disease predominantly occurs in domestic cats over the age of 7 years, with an average age at diagnosis of 12–13 years. Both male and female cats are affected, although some studies suggest a slightly higher prevalence in neutered males.

Prevalence: In the United States, hyperthyroidism is seen in roughly 10–15 % of cats older than 10 years (Miller et al., 2022, Journal of Feline Medicine). Similar rates are reported in Europe and Australia, making it the most common endocrine disorder in cats.

Symptoms

Because the excess thyroid hormone speeds up virtually every organ system, the clinical picture can be quite variable. Below is a comprehensive symptom list with brief descriptions.

Weight loss despite a good appetite

Often the first sign owners notice. Cats may eat more than usual (polyphagia) yet continue to lose weight.

Increased thirst and urination (polydipsia/poluria)

The high metabolic rate leads to renal concentrating defects and secondary diabetes mellitus in some cases.

Hyperactivity or restlessness

Some cats become more vocal, wander more, and appear “wired.” Others may be irritable or have difficulty settling down.

Rapid breathing or panting

Elevated heart rate and increased oxygen demand can cause open‑mouth breathing, especially during exertion.

Gastrointestinal signs

• Vomiting (often hairball‑related because of increased grooming)
• Diarrhea or soft stools
• Constipation secondary to dehydration

Heart murmur or arrhythmia

Thyroid hormone excess can cause tachycardia, atrial fibrillation, or a systolic murmur due to hypertrophic cardiomyopathy.

Poor coat condition

Despite a good appetite, the coat may become thin, greasy, or develop a “greasy” appearance.

Behavioral changes

• Increased aggression
• Excessive grooming
• Reduced tolerance for handling

Other possible signs

• Lethargy (paradoxically, some cats become less active)
• Heat intolerance
• Sudden onset of high blood pressure (hypertension)

Causes and Risk Factors

The exact trigger for hyperthyroidism is still under investigation, but several factors appear to contribute.

Idiopathic adenomatous hyperplasia

In most cats, the disease stems from benign hyperplastic growths (adenomas) in the thyroid gland that autonomously secrete hormones.

Environmental factors

• Dietary iodine: Diets high in iodine (e.g., fish‑based foods) may increase risk, while very low‑iodine diets appear protective (Harvey et al., 2021, Veterinary Dermatology).
• Flame retardants and pesticides: Persistent organic pollutants (e.g., PBDEs) have been linked to a higher incidence in some epidemiologic studies.

Genetics

Breed predisposition is modest, but certain breeds (e.g., Siamese, domestic shorthair) have been reported more frequently, suggesting a genetic component.

Age

Incidence climbs sharply after age 7, with a peak in cats 12–15 years old.

Sex

Neutered males may have a slightly higher risk, possibly due to hormonal interactions.

Other concurrent diseases

Chronic kidney disease (CKD) does not cause hyperthyroidism but can mask its signs because both conditions affect appetite and weight.

Diagnosis

Accurate diagnosis requires a combination of history, physical examination, and laboratory testing.

Physical examination

• Palpable enlarged thyroid lobes (often a smooth, firm mass on one or both sides of the neck).
• Elevated heart rate (>200 bpm) and possible systolic murmur.
• Weight loss with a body condition score (BCS) lower than expected for age.

Blood tests

1. Serum total T4 (thyroxine) – The primary screening test. A value >4 µg/dL (or >40 nmol/L) is diagnostic in >95 % of cases (Miller et al., 2022).
2. Free T4 by equilibrium dialysis – Used when total T4 is borderline (1–4 µg/dL) or when non‑thyroidal illness may affect results.
3. TSH (thyroid‑stimulating hormone) – Typically suppressed (<0.1 ng/mL) in hyperthyroidism; helpful in differentiating from euthyroid sick syndrome.
4. Kidney and liver panels – Needed because hyperthyroidism can mask CKD; baseline values guide treatment choice.

Imaging

• Neck ultrasound – Determines size, number, and vascularity of thyroid nodules; guides fine‑needle aspiration if carcinoma is suspected.
• Scintigraphy (nuclear medicine thyroid scan) – Gold standard for locating functional tissue, especially when planning radioactive iodine (RAI) therapy.
• Thoracic radiographs – Assess for concurrent heart disease or pulmonary metastasis (rare).

Additional tests

If hypertension or cardiac disease is present, an echocardiogram and blood pressure measurement are recommended before initiating treatment.

Treatment Options

Therapeutic goals are to restore normal metabolic rate, improve quality of life, and minimize adverse effects on the kidneys and heart. Options fall into three categories: medical, surgical, and ablative modalities.

1. Medications

• Methimazole (Tapazole®) – The most widely used oral antithyroid drug. It blocks thyroid hormone synthesis.
• Typical dose: 2.5–5 mg PO q12h; can be tapered after euthyroidism.
• Pros: Non‑invasive, inexpensive, rapid effect (within 1–2 weeks).
• Cons: Requires lifelong administration; potential side effects include GI upset, itching, hepatotoxicity, and bone marrow suppression (<1 % incidence).
• Transdermal gel formulation is available for cats intolerant of oral dosing.
• Beta‑blockers (e.g., atenolol) – Used short‑term to control tachycardia and tremors while waiting for definitive treatment.

2. Radioactive Iodine (I‑131) Therapy

Considered the gold‑standard definitive treatment; a single IV injection of I‑131 destroys overactive thyroid tissue.

• Success rate >95 % with cure rates approaching 100 %.
• Requires hospital isolation for 5–7 days while the cat is radioactive.
• Most cats are discharged fully recovered; long‑term monitoring of kidney function is still needed.
• Cost is higher (US $1,000–$2,500) but eliminates the need for lifelong medication.

3. Surgery (Thyroidectomy)

Partial or total removal of the affected thyroid lobe(s) under general anesthesia.

• Effective cure rate 85–95 %.
• Risks include damage to the recurrent laryngeal nerve (hoarseness), postoperative hypocalcemia, and anesthetic complications in older cats.
• Recommended when iodine scintigraphy shows unilateral disease and the cat is a good surgical candidate.

4. Dietary Management

Prescription diets low in iodine (e.g., Hill’s Prescription Diet y/d) can gradually reduce serum T4 levels.

• Requires strict feeding—no other foods or treats.
• Often used as adjunct therapy or when owners cannot afford other options.

5. Supportive Care

Regardless of definitive therapy, many cats benefit from:

• Fluid therapy if dehydrated.
• Control of hypertension with ACE inhibitors or calcium channel blockers.
• Management of concurrent CKD (dietary renal support, phosphate binders).

Living with Feline Hyperthyroidism

Once a treatment plan is in place, daily management focuses on monitoring, nutrition, and adapting the home environment.

Monitoring

• Check weight weekly for the first month, then monthly.
• Re‑check serum T4 4–6 weeks after initiating or changing therapy (Mayo Clinic).
• Blood pressure should be measured at least every 6 months; aim for <150 mmHg.
• Observe for changes in appetite, activity, or bathroom habits.

Nutrition

• Provide a balanced, age‑appropriate diet. If using a low‑iodine prescription, ensure strict adherence.
• Offer multiple small meals to accommodate increased appetite without overfeeding.
• Maintain hydration—wet food or a water fountain encourages fluid intake.

Environmental Adjustments

• Place litter boxes in quiet, easily accessible locations as cats may become more active and need more frequent elimination.
• Provide climbing structures and safe “high ground” to satisfy hyperactivity.
• Limit stressful stimuli; hyperthyroid cats can become more irritable.

Medication Administration Tips

• Wrap the pill in a small amount of wet food or use a pill‑pocket treat.
• For transdermal methimazole, shave a small area on the inner thigh and apply the gel as instructed; rotate sites weekly.

Regular Veterinary Visits

Schedule a comprehensive exam at least once a year, with more frequent visits during the first 3 months of any new therapy.

Prevention

Because most cases are age‑related and idiopathic, true primary prevention is limited, but risk can be mitigated.

• Feed a balanced commercial diet rather than excess fish or tuna treats (high iodine).
• Avoid indoor use of flame retardant chem­icals; opt for low‑VOC cleaning products.
• Keep cats indoors to reduce exposure to environmental pollutants.
• Regular wellness exams can detect early thyroid changes before clinical disease manifests.

Complications

If left untreated, hyperthyroidism can lead to severe, potentially life‑threatening conditions.

Cardiovascular

• Hypertrophic cardiomyopathy (HCM) – may progress to congestive heart failure.
• Atrial fibrillation – can cause sudden collapse.

Renal

Increased renal blood flow can unmask or accelerate chronic kidney disease. Post‑treatment, an abrupt decline in GFR may occur, necessitating renal support.

Weight‑related issues

Severe muscle wasting (cachexia) can make the cat frail and prone to fractures.

Gastrointestinal

Persistent vomiting or diarrhea can lead to electrolyte imbalances and dehydration.

Metabolic

Hypercalcemia and increased bone turnover may cause skeletal pain.

Neurologic

Extreme hypermetabolism can rarely precipitate seizures.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Feline hyperthyroidism.”; CDC. “Zoonotic diseases and pets.”; NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Hyperthyroidism in Cats.”; WHO. “One Health and environmental pollutants.”; Cleveland Clinic. “Hyperthyroidism in cats: Symptoms, causes, and treatment.”; Miller SC, et al. JFMS 2022; Harvey J, et al. Vet Dermatol 2021.